These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 15532789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [Abstract] [Full Text] [Related]

  • 3. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
    Kim MW, Kim WH, Wang HJ, Chung JB, Chun M.
    Hepatogastroenterology; 2001 Aug; 48(41):1298-301. PubMed ID: 11677950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW, Zhao P, Zhou ZX, Tian YT, Zhao DB, Wang CF.
    Zhonghua Wai Ke Za Zhi; 2009 May 01; 47(9):677-80. PubMed ID: 19615237
    [Abstract] [Full Text] [Related]

  • 7. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
    Aramaki M, Matsumoto T, Shibata K, Himeno Y, Yada K, Hirano S, Sasaki A, Kawano K, Kitano S.
    Hepatogastroenterology; 2004 May 01; 51(60):1609-11. PubMed ID: 15532788
    [Abstract] [Full Text] [Related]

  • 8. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM, Kim MJ, Pi DY, Jo D, Cho HJ, Yu E, Ro JY.
    Cancer; 2005 Aug 15; 104(4):802-10. PubMed ID: 15959914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.
    Am J Clin Oncol; 2012 Apr 15; 35(2):136-40. PubMed ID: 21325937
    [Abstract] [Full Text] [Related]

  • 11. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K.
    Am J Gastroenterol; 2009 Nov 15; 104(11):2747-53. PubMed ID: 19603009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Liver metastases after curative resection in patients with distal bile duct cancer.
    Takao S, Shinchi H, Uchikura K, Kubo M, Aikou T.
    Br J Surg; 1999 Mar 15; 86(3):327-31. PubMed ID: 10201773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 17. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B, Dartevelle PG, Fadel E, Mussot S, Chapelier A.
    Ann Thorac Surg; 2008 Oct 15; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [Abstract] [Full Text] [Related]

  • 18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.
    Ann Thorac Surg; 2009 Jul 15; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [Abstract] [Full Text] [Related]

  • 19. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB, Park SW, Kim KS, Choi JS, Lee WJ.
    J Surg Oncol; 2009 May 01; 99(6):335-42. PubMed ID: 19226533
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.